Intracranial Hemorrhages Clinical Trial
— NIRS-DETECTOfficial title:
A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma
NCT number | NCT06404645 |
Other study ID # | LY2024-054-B |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 1, 2024 |
Est. completion date | December 31, 2024 |
Verified date | May 2024 |
Source | RenJi Hospital |
Contact | Ru Gong |
Phone | 13512193229 |
gongru1987[@]126.com | |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This trial is a clinical prospective observational study. Cases meeting the entry criteria undergo near-infrared spectroscopy(NIRS)detection. Data collection mainly includes hematoma thickness on cranial CT, and bilateral NIRS data.This trial tries to explore the reliability and accuracy of NIRS detection of subcranial hematoma.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | December 31, 2024 |
Est. primary completion date | July 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Age above 18 years old 2. Unilateral subcranial hemorrhage confirmed by cranial CT Exclusion Criteria: 1. Bilateral subcranial hemorrhage 2. Intracranial pneumoperitoneum in the location of the hemorrhage on cranial CT 3. Obvious skull fracture in the location of hemorrhage on cranial CT |
Country | Name | City | State |
---|---|---|---|
China | Brain Injury Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
RenJi Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | NIRS data1 | NIRS data of bleeding side and the opposite side | 3 months | |
Secondary | NIRS data2 | relationship between NIRS data and thickness of haematoma | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03969732 -
Multimodal Biomarkers for Diagnosis and Prognosis in CAA
|
Phase 3 | |
Recruiting |
NCT05968053 -
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
|
||
Recruiting |
NCT02962349 -
TRansfusion Strategies in Acute Brain INjured Patients
|
N/A | |
Recruiting |
NCT03950076 -
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
|
Phase 4 | |
Completed |
NCT03542656 -
Application of Amyloid PET in Cerebral Amyloid Angiopathy
|
Phase 3 | |
Active, not recruiting |
NCT05626504 -
Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
|
||
Recruiting |
NCT03495206 -
Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet
|
Phase 1 | |
Not yet recruiting |
NCT04229758 -
Restarting Anticoagulation After Traumatic Intracranial Hemorrhage
|
Phase 3 | |
Recruiting |
NCT02135783 -
Decompressive Craniectomy Combined With Hematoma Removal to Treat ICH
|
N/A | |
Enrolling by invitation |
NCT02050971 -
Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates
|
Phase 1 | |
Completed |
NCT01193270 -
Vitamin E for Extremely Preterm Infants
|
Phase 1 | |
Completed |
NCT02881957 -
Hypovitaminosis D in Neurocritical Patients
|
Phase 2/Phase 3 | |
Completed |
NCT03364634 -
Intracranial Pressure After Decompressive Craniectomy
|
N/A | |
Completed |
NCT00226096 -
Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
|
N/A | |
Recruiting |
NCT06081283 -
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
|
Phase 4 | |
Recruiting |
NCT04459806 -
Intracranial PrEssure Time dOse (ImPETO)
|
||
Recruiting |
NCT05874050 -
Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
|
||
Not yet recruiting |
NCT05138341 -
Minimal Invasive Surgical Intracerebral Hemorrhage Removal
|
N/A | |
Terminated |
NCT03660618 -
LSFG-SKIN, Laser Speckle Flowgraphy
|
N/A | |
Recruiting |
NCT06370520 -
Screening Emotions in Adolescents at the Hospital for mTBI
|